Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

Princeton University awarded honorary degrees to Omar M. Yaghi, Daniel Chee Tsui, Nancy Weiss Malkiel, Joshua ...

The next-gen immunotherapies market is evolving with biotech advances, rising cancer cases, new therapies, funding, and ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

India’s strength in pharmaceuticals is well known--but what’s unfolding now goes beyond low-cost generics and vaccines. With ...

Explore how CRISPR could become a powerful antiviral tool against HIV, Hepatitis B, HPV, and more, based on emerging research.

For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body—a ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

A “genetic surgery” or “interventional genetics” system for individualized treatments would be a marriage of drug development ...